Delivery Order SPE2DB20D2104-SPE2DB24FT42W
- Not listed
- This federal contract award, valued at $2,745.90, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 0.1% Ointment 30GM, a prescription medication, to support federal government healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award is for the supply of Tacrolimus 0.1% ointment, 30 grams, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,634.95, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of January 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,444.73 firm fixed-price delivery order is for the supply of Tacrolimus 0.1% ointment, a medication used to treat various skin conditions. The contract has a completion date of January 5, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award is for the delivery of Tacrolimus 0.1% ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $1,920.55 and a completion date of April 15, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,139.56, is for the delivery of Tacrolimus 0.1% ointment, a pharmaceutical product used for medical treatment. The contract has a firm fixed price and an ultimate completion date of May 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- This federal contract award, valued at $1,273.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 0.1% ointment in 60 gram tubes. The award is not associated with a set-aside program and is a firm fixed-price delivery order contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tacrolimus 0.1% Ointment, a specialty medication used for various medical conditions. The contract has a ceiling value of $2,823.73 and a period of performance through January 8, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation, indicating...
- This federal contract award, with an ID of SPE2DB20D3505|SPE2DB24FU5H0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TACROLIMUS 0.1% OINTMENT 30GM, with an ultimate completion date of June 28, 2024 and a ceiling value of $3,498.23. The contract is a Delivery Order with a Firm Fixed Price pricing type. There was no set-aside designation used for this award....
- This federal contract award is for the delivery of 100 capsules of the medication Tacrolimus 0.5 mg (immediate release) to the Defense Logistics Agency (DLA). The contract, a firm fixed-price delivery order valued at $1,856.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of October 21,...
- This federal contract award is a delivery order (SPE2DX15D6028|SPE2DX25FWFCE) issued by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,355.00, is for the delivery of TACROLIMUS .1% 30GM 1S, a pharmaceutical product, with a completion date of November 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT42WDelivery Order
This federal contract award, valued at $2,070.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 0.1% Ointment, a prescription medication, with a completion date of April 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 4/3/24 |